Musculoskeletal diseases
Conditions
Interventions
This is a double-blind, placebo-controlled randomized clinical trial to be performed with 30 healthy young men with no recent experience with lower limb strength training, aged 18-35 years. Volunteers
Other
Sponsors
Universidade Federal do Rio Grande do Norte
Universidade Federal do Rio Grande do Norte
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Be a healthy male, aged 18-35 years and classified as irregularly active or active in the International Physical Activity Questionaire (IPAQ); Not being involved in strength training programs for lower limbs; not with a body mass index (BMI) of less than 18.5 kg / m-2 and greater than 30 kg / m-2; not be smokers or who use vasoactive medications and nutritional supplements regularly. Do not report musculoskeletal injury to lower limbs within 3 months prior to testing; not having uncontrolled diabetes mellitus or blood pressure; have no inflammatory rheumatologic condition or severe cardiovascular and / or pulmonary disease that prevents them from performing the evaluation and the proposed exercise; not having psychiatric disease and malignant tumors; not have presented Zika or Chikungunya in the last year.
Exclusion criteria
Exclusion criteria: Missing some day of collection; at any time and for any reason expressing an intention to leave the study; present a health problem that prevents them from continuing to participate in the research; use of medications, electrotherapeutic equipment or other therapeutic resources to improve pain and performance during the collection period; practicing unusual or strenuous physical activities during the days of collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Delayed-onset muscle soreness measured by the visual analogue pain scale (VAS) of 100 millimeters, where 0 is understood as no pain and 100 as the largest pain ever experienced by the volunteer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Isometric torque measured by isokinetic dynamometer.;Range of motion of the knee measured by a goniometer.;Thigh circumference measured by perimetry;Serum creatine kinase levels measured from blood sample collection;Perception of discomfort during ischemic preconditioning and perceived exertion during eccentric exercise measured by the visual analogue scale (EVA) of the 0 a 100 mm and the Borg scale, respectively. | — |
Countries
Brazil
Contacts
Public ContactMikhail Santos Cerqueira
Universidade Federal do Rio Grande do Norte
Outcome results
None listed